Literature DB >> 27888303

Dual-energy CT workflow: multi-institutional consensus on standardization of abdominopelvic MDCT protocols.

Bhavik N Patel1, Lauren Alexander2, Brian Allen3, Lincoln Berland4, Amir Borhani5, Achille Mileto3, Courtney Moreno2, Desiree Morgan4, Dushyant Sahani6, William Shuman7, Eric Tamm8, Mitchell Tublin5, Benjamin Yeh9, Daniele Marin3.   

Abstract

PURPOSE: To standardize workflow for dual-energy computed tomography (DECT) involving common abdominopelvic exam protocols.
MATERIALS AND METHODS: 9 institutions (4 rsDECT, 1 dsDECT, 4 both) with 32 participants [average # years (range) in practice and DECT experience, 12.3 (1-35) and 4.6 (1-14), respectively] filled out a single survey (n = 9). A five-point agreement scale (0, 1, 2, 3, 4-contra-, not, mildly, moderately, strongly indicated, respectively) and utilization scale (0-not performing and shouldn't; 1-performing but not clinically useful; 2-performing but not sure if clinically useful; 3-not performing it but would like to; 4-performing and clinically useful) were used. Consensus was considered with a score of ≥2.5. Survey results were discussed over three separate live webinar sessions.
RESULTS: 5/9 (56%) institutions exclude large patients from DECT. 2 (40%) use weight, 2 (40%) use transverse dimension, and 1 (20%) uses both. 7/9 (78%) use 50 keV for low and 70 keV for medium monochromatic reconstructed images. DECT is indicated for dual liver [agreement score (AS) 3.78; utilization score (US) 3.22] and dual pancreas in the arterial phase (AS 3.78; US 3.11), mesenteric ischemia/gastrointestinal bleeding in both the arterial and venous phases (AS 2.89; US 2.79), RCC exams in the arterial phase (AS 3.33; US 2.78), and CT urography in the nephrographic phase (AS 3.11; US 2.89). DECT for renal stone and certain single-phase exams is indicated (AS 3.00).
CONCLUSIONS: DECT is indicated during the arterial phase for multiphasic abdominal exams, nephrographic phase for CTU, and for certain single-phase and renal stone exams.

Entities:  

Keywords:  Consensus; Dual-energy CT; Workflow

Mesh:

Year:  2017        PMID: 27888303     DOI: 10.1007/s00261-016-0966-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

Review 1.  Advanced imaging techniques for chronic pancreatitis.

Authors:  Anushri Parakh; Temel Tirkes
Journal:  Abdom Radiol (NY)       Date:  2020-05

2.  Virtual monoenergetic images from dual-energy CT: systematic assessment of task-based image quality performance.

Authors:  Davide Cester; Matthias Eberhard; Hatem Alkadhi; André Euler
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Low kV versus dual-energy virtual monoenergetic CT imaging for proven liver lesions: what are the advantages and trade-offs in conspicuity and image quality? A pilot study.

Authors:  G Jay Hanson; Gregory J Michalak; Robert Childs; Brian McCollough; Anil N Kurup; David M Hough; Judson M Frye; Jeff L Fidler; Sudhakar K Venkatesh; Shuai Leng; Lifeng Yu; Ahmed F Halaweish; W Scott Harmsen; Cynthia H McCollough; J G Fletcher
Journal:  Abdom Radiol (NY)       Date:  2018-06

Review 4.  Recognizing and Minimizing Artifacts at Dual-Energy CT.

Authors:  Anushri Parakh; Chansik An; Simon Lennartz; Prabhakar Rajiah; Benjamin M Yeh; Frank J Simeone; Dushyant V Sahani; Avinash R Kambadakone
Journal:  Radiographics       Date:  2021-02-19       Impact factor: 5.333

5.  Dual-Energy CT: Lower Limits of Iodine Detection and Quantification.

Authors:  Megan C Jacobsen; Erik N K Cressman; Eric P Tamm; Dodge L Baluya; Xinhui Duan; Dianna D Cody; Dawid Schellingerhout; Rick R Layman
Journal:  Radiology       Date:  2019-06-25       Impact factor: 29.146

6.  Diagnostic performance of single-phase dual-energy CT to differentiate vascular and nonvascular incidental renal lesions on portal venous phase: comparison with CT.

Authors:  Domenico Mastrodicasa; Martin J Willemink; Nikhil Madhuripan; Ranjit Singh Chima; Amanzo A Ho; Yuqin Ding; Daniele Marin; Bhavik N Patel
Journal:  Eur Radiol       Date:  2021-06-11       Impact factor: 7.034

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.